What is Beijing Tiantan Biological Products Co., Ltd.'s (600161.SS) StockRank?

MoatMap's StockRank for Beijing Tiantan Biological Products Co., Ltd. (600161.SS) is 47/100, with a Hold signal. This is a composite score combining Quality (68), Value (39), and Momentum (31) factor ranks across MoatMap's 19,000+ stock universe.

Does Beijing Tiantan Biological Products Co., Ltd. have an economic moat?

Beijing Tiantan Biological Products Co., Ltd. (600161.SS) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Beijing Tiantan Biological Products Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Beijing Tiantan Biological Products Co., Ltd. (600161.SS) is Hold, based on a StockRank of 47/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Beijing Tiantan Biological Products Co., Ltd. in?

Beijing Tiantan Biological Products Co., Ltd. (600161.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600161.SS

HOLDREMOVE

Beijing Tiantan Biological Products Co., Ltd. · Healthcare · China · $4.0B · Avg Vol: $22M/d

StockRank

P/E (TTM)

25.9x

ROE

8.8%

D/E

0.0x

Dividend %

1.6%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Beijing Tiantan Biological is a high-quality blood products manufacturer in China with strong regulatory barriers. However, it does not directly align with our CDMO pricing power theme as it focuses on plasma products rather than contract manufacturing.

COMPANY DESCRIPTION

Beijing Tiantan Biological Products is China's leading biopharmaceutical company specializing in plasma-derived therapies, including albumin and immunoglobulins. As a subsidiary of Sinopharm, the company operates the nation's largest network of plasma donation centers, securing a critical raw material advantage. Its strict safety standards and massive scale create a high barrier to entry in a highly regulated market.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	630M	766M	891M	912M	13.1%
EPS	0.07	0.08	0.12	0.08	7.6%
Shares	2.0B	2.0B	2.0B	2.0B	+0.0%
Debt	60M	6M	8M	24M	-26.4%
Equity	1.3B	1.5B	1.6B	1.7B	10.1%
Op CF	166M	354M	121M	50M	-33.0%
Inv CF	-277M	-184M	-275M	18M	—
Fin CF	-56M	-75M	-55M	-65M	—

PRICE (1M)-10.9%

SMA 50SMA 200

$1.88

RSI (14)

40.7

52W High

$3.24

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

11.8%78.5

ROE

8.8%69.0

GP/Assets

14.9%35.0

Op. Margin

19.3%81.2

FCF/Assets

-0.1%50.1

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

0.01x91.8

Current Ratio

8.82x84.3

Value

P/E (TTM)

25.9x44.0

EV/EBITDA

13.5x31.2

P/FCF

—N/A

P/B

2.1x53.6

P/S

4.2x46.1

Div Yield

1.6%41.2

Momentum

52W High %

58%36.3

RS 6M

-34%35.6

SMA 50/200

0.84x18.6

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+37%47.1

Q Growth

-48%10.8

FUNDAMENTALS

Market Cap

$4.0B

P/E (Forward)

18.9x

Gross Margin

41.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600161.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
600161.SS	Beijing Tiantan Biological Products Co., Ltd.(you)	$4.0B	47	HOLD
301301.SZ	Yili Chuanning Biotechnology Co.,Ltd.	$2.9B	46	HOLD
2696.HK	Shanghai Henlius Biotech, Inc.	$4.8B	44	HOLD
9969.HK	InnoCare Pharma Limited	$2.6B	48	HOLD
3759.HK	Pharmaron Beijing Co., Ltd.	$4.1B	59	HOLD
688319.SS	Chengdu Olymvax Biopharmaceuticals Inc.	$2.1B	45	HOLD
688278.SS	Xiamen Amoytop Biotech Co., Ltd.	$3.4B	59	HOLD
600201.SS	Jinyu Bio-technology Co., Ltd.	$1.9B	48	HOLD
002252.SZ	Shanghai RAAS Blood Products Co., Ltd.	$5.2B	37	HOLD
688222.SS	HitGen Inc.	$1.8B	47	HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Beijing Tiantan Biological Products Co., Ltd. (600161.SS) — Stock Score Summary

Beijing Tiantan Biological Products Co., Ltd. (600161.SS) has a MoatMap StockRank of 47/100 based on Quality (68/100), Value (39/100), and Momentum (31/100) factor scores. The current signal is HOLD. Beijing Tiantan Biological is a high-quality blood products manufacturer in China with strong regulatory barriers. However, it does not directly align with our CDMO pricing power theme as it focuses on plasma products rather than contract manufacturing.

Key Financial Metrics

Price	$1.88
Market Cap	$4.0B
P/E (TTM)	25.86
P/E (Forward)	18.91
Price/Book	2.11
Return on Equity	8.8%
Return on Invested Capital	11.8%
Debt/Equity	0.59
Gross Margin	41.2%
Operating Margin	19.3%
Revenue Growth	-13.4%
Dividend Yield	1.6%
Free Cash Flow	$-516K

Beijing Tiantan Biological Products Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Tiantan Biological Products Co., Ltd.’s (600161.SS) StockRank?: MoatMap’s StockRank for Beijing Tiantan Biological Products Co., Ltd. (600161.SS) is 47/100, with a Hold signal. It is a composite of Quality (68), Value (39), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does Beijing Tiantan Biological Products Co., Ltd. have an economic moat?: Beijing Tiantan Biological Products Co., Ltd. (600161.SS) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Tiantan Biological Products Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Beijing Tiantan Biological Products Co., Ltd. (600161.SS) is Hold, based on a StockRank of 47/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Tiantan Biological Products Co., Ltd. in?: Beijing Tiantan Biological Products Co., Ltd. (600161.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).